+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levamisole"

Anthelmintic Drugs Market Report 2025 - Product Thumbnail Image

Anthelmintic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Thumbnail Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • July 2023
  • 1568 Pages
  • 4 Results (Page 1 of 1)
Loading Indicator

Levamisole is a drug used to treat parasitic infections, such as roundworm and hookworm. It is also used to treat certain types of cancer, such as colorectal cancer. Levamisole is a member of the anthelmintic class of drugs, which are used to treat parasitic infections caused by worms. It works by paralyzing the worms, which are then expelled from the body. Levamisole is used in the treatment of infectious diseases, such as malaria, schistosomiasis, and filariasis. It is also used to treat certain types of cancer, such as colorectal cancer. Levamisole is available in both oral and injectable forms. It is typically administered as a single dose, but may be given in multiple doses depending on the severity of the infection. The drug is generally well tolerated, with few side effects. The market for levamisole is growing, as it is increasingly being used to treat a variety of infectious diseases and cancers. It is also being used in combination with other drugs to treat more complex infections. Some companies in the levamisole market include Merck, Pfizer, GlaxoSmithKline, and Sanofi. Show Less Read more